Literature DB >> 11487033

Apoptosis as a determinant of atherothrombosis.

A Tedgui1, Z Mallat.   

Abstract

Clinical manifestations of atherosclerosis are the consequences of atherosclerotic plaque rupture that triggers thrombus formation. Tissue factor (TF) is a key element in the initiation of the coagulation cascade and is crucial in thrombus formation following plaque disruption. TF activity is highly dependent on the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed on the cell surface during apoptotic death conferring a potent procoagulant activity to the apoptotic cell. Apoptosis occurs in the human atherosclerotic plaque and shed membrane apoptotic microparticles rich in PS are produced in considerable amounts within the lipid core. These microparticles carry almost all TF activity and are responsible for the procoagulant activity of the plaque. Moreover, luminal endothelial cell apoptosis might be responsible for thrombus formation on eroded plaques without rupture. Apoptosis might also play a major role in blood thrombogenicity via circulating procoagulant microparticles that are found at high levels in patients with acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487033

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  The procoagulant potential of environmental particles (PM10).

Authors:  P S Gilmour; E R Morrison; M A Vickers; I Ford; C A Ludlam; M Greaves; K Donaldson; W MacNee
Journal:  Occup Environ Med       Date:  2005-03       Impact factor: 4.402

2.  HUVECs from newborns with a strong family history of myocardial infarction overexpress adhesion molecules and react abnormally to stimulating agents.

Authors:  A Paez; A R Méndez-Cruz; E Varela; E Rodriguez; J Guevara; L Flores-Romo; L F Montaño; F A Massó
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.

Authors:  Hsiu-Hui Chen; Cristina P Vicente; Li He; Douglas M Tollefsen; Tze-Chein Wun
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

4.  Involvement of CaSR in hyperglycemia-induced macroangiopathy and related mechanism.

Authors:  Jin-Ping Lu; Jiang-Hua Ren; Ling Chen; Xia Li; Hui-Li Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

Review 5.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

Authors:  Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

Review 6.  Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

Authors:  L M Riou; A Broisat; J Dimastromatteo; G Pons; D Fagret; C Ghezzi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

Authors:  Marijke C Trappenburg; Muriel van Schilfgaarde; Marina Marchetti; Henri M Spronk; Hugo ten Cate; Anja Leyte; Wim E Terpstra; Anna Falanga
Journal:  Haematologica       Date:  2009-06-08       Impact factor: 9.941

8.  Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea.

Authors:  Ali A El Solh; Morohunfolu E Akinnusi; Ilya G Berim; A Misha Peter; Linda L Paasch; Kristie R Szarpa
Journal:  Sleep Breath       Date:  2008-04-09       Impact factor: 2.816

Review 9.  Crosstalk between red blood cells and the immune system and its impact on atherosclerosis.

Authors:  Brigitta Buttari; Elisabetta Profumo; Rachele Riganò
Journal:  Biomed Res Int       Date:  2015-02-04       Impact factor: 3.411

10.  Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis.

Authors:  Claudio Lunardi; Marzia Dolcino; Dimitri Peterlana; Caterina Bason; Riccardo Navone; Nicola Tamassia; Elisa Tinazzi; Ruggero Beri; Roberto Corrocher; Antonio Puccetti
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.